Successful experimental treatment of congenital ichthyosis in an infant

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Deffenbacher, Brandy ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; EMOLLIENT AGENT; UREA;

ARTICLE; CASE REPORT; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ECTROPION; ERYTHEMA; ERYTHRODERMA; EXPERIMENTAL THERAPY; HUMAN; INFANT; LAMELLAR ICHTHYOSIS; MALE; NEWBORN; OFF LABEL DRUG USE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN IRRITATION; SKIN TIGHTNESS; TOPICAL TREATMENT;

EID: 84876559299     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-008688     Document Type: Article

References (7)

1. DiGiovanna JJ, Bostom-Robinson R. Ichthyosis: etiology, diagnosis, and management. Am J Clin Dermatol 2003;4:81-95.
2. Sarici SU, Sahin M, Yurdakok M. Topical N-acetylcysteine treatment in neonatal ichthyosis. Turk J Pediatr 2003;45:245-7.
3. Bassoti A, Moreno S, Criado E. Successful treatment with topical N-acetylcysteine in urea in five children with congenital lamellar ichthyosis. Pediatr Dermatol 2011;28:451-5.
4. Hofmann B, Stege H, Ruzicka T, et al. Effect of topical tazarotene in the treatment of congenital ichthyosis. Br J Dermatol 1999;141:642-6.
5. Liu RH, Becker B, Gunkel J, et al. Rapid improvement in digital ischemia and acral contracture in a collodion baby treated with topical tazarotene. J Drugs Dermatol 2010;9:713-16.
6. Redondo P, Bauza A. Topical N-acetylcysteine for lamellar ichthyosis. Lancet 1999;354:1880.
7. Sekharam M, Trotti A, Cunnick J, et al. Suppression of fibroblast cell cycle progress in G1 phase by N-acetylcysteine. Toxicol Appl Pharmacol 1998;149:210-16.